We are live on ! Find out more
FAM

Fred Alger Management Portfolio holdings

AUM $22.8B
1-Year Est. Return 64.63%
This Fund
S&P 500
This Quarter Est. Return
+10.33%
1 Year Est. Return
+64.63%
3 Year Est. Return
+243.99%
5 Year Est. Return
+318.3%
10 Year Est. Return
+1,899.64%
AUM
$20.6B
AUM Growth
+$404M
Cap. Flow
-$918M
Cap. Flow %
-4.46%
Top 10 Hldgs %
45.88%
Holding
486
New
43
Increased
157
Reduced
204
Closed
61

Top Buys

Rank Stock Value
1
APP icon
Applovin
APP
+$271M
2
CEG icon
Constellation Energy
CEG
+$108M
3
HUBS icon
HubSpot
HUBS
+$83.9M
4
AAPL icon
Apple
AAPL
+$83.5M
5
EQIX icon
Equinix
EQIX
+$56.3M

Sector Composition

Rank Sector Weight
1 Technology 41.24%
2 Healthcare 15.44%
3 Communication Services 13.11%
4 Consumer Discretionary 10.67%
5 Industrials 10.09%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PLD icon
301
Prologis
PLD
$137B
$2.79M 0.01%
24,814
+1,297
+6% +$144K
JCI icon
302
Johnson Controls International
JCI
$85.6B
$2.75M 0.01%
41,352
MDT icon
303
Medtronic
MDT
$111B
$2.71M 0.01%
34,411
PFE icon
304
Pfizer
PFE
$144B
$2.67M 0.01%
95,592
+5,932
+7% +$163K
EHC icon
305
Encompass Health
EHC
$11.5B
$2.59M 0.01%
+30,162
New +$2.53M
PAYC icon
306
Paycom
PAYC
$7.54B
$2.49M 0.01%
17,400
+8,281
+91% +$1.42M
DLO icon
307
dLocal
DLO
$4.38B
$2.47M 0.01%
304,889
-8,819
-3% -$104K
SYY icon
308
Sysco
SYY
$40.7B
$2.44M 0.01%
34,205
PETQ
309
DELISTED
PetIQ, Inc. Class A Common Stock
PETQ
$2.43M 0.01%
110,339
-1,550
-1% -$29.8K
BMRN icon
310
BioMarin Pharmaceuticals
BMRN
$12B
$2.43M 0.01%
29,516
-1,664
-5% -$139K
GD icon
311
General Dynamics
GD
$106B
$2.42M 0.01%
8,351
+679
+9% +$199K
CQP icon
312
Cheniere Energy
CQP
$31B
$2.31M 0.01%
46,993
AMG icon
313
Affiliated Managers Group
AMG
$9.78B
$2.28M 0.01%
14,591
-289
-2% -$46K
KROS icon
314
Keros Therapeutics
KROS
$199M
$2.24M 0.01%
48,993
-16,887
-26% -$907K
TTEK icon
315
Tetra Tech
TTEK
$8.7B
$2.17M 0.01%
53,145
+38,770
+270% +$1.58M
TEM
316
Tempus AI
TEM
$7.72B
$2.17M 0.01%
+61,920
New +$1.9M
DUOL icon
317
Duolingo
DUOL
$6.56B
$2.07M 0.01%
+9,919
New +$2.03M
EWCZ
318
DELISTED
European Wax Center
EWCZ
$2.02M 0.01%
203,345
-3,061
-1% -$34.8K
MTN icon
319
Vail Resorts
MTN
$5.6B
$2M 0.01%
11,117
+633
+6% +$126K
WIX icon
320
WIX.com
WIX
$2.45B
$1.97M 0.01%
+12,382
New +$1.78M
HLVX
321
DELISTED
HilleVax
HLVX
$1.97M 0.01%
136,166
+12,044
+10% +$165K
ON icon
322
ON Semiconductor
ON
$32.8B
$1.93M 0.01%
28,144
-36,898
-57% -$2.59M
GILD icon
323
Gilead Sciences
GILD
$167B
$1.88M 0.01%
27,357
+2,442
+10% +$163K
IBM icon
324
IBM
IBM
$214B
$1.87M 0.01%
10,784
-149,665
-93% -$26M
FITB
325
Fifth Third Bancorp
FITB
$52.4B
$1.86M 0.01%
50,844
+3,978
+8% +$145K

Similar funds

Fred Alger Management's Q2 2024 Portfolio in Review

As of Q2 2024, Fred Alger Management held 486 positions worth $20.6B, up 2% from $20.2B the previous quarter. Its ten largest holdings account for 46% of the portfolio.

Fred Alger Management withdrew a net $918M in Q2 2024, closing 61 positions and reducing 204 holdings. Its most notable exit was Shockwave Medical, Inc. Common Stock, an estimated $67.4M position sold in full.

By sector, the portfolio is most concentrated in Technology at 41% of assets, up from 39% a quarter earlier, followed by Healthcare and Communication Services.

Against the trend, Fred Alger Management opened a new position in Applovin worth $291M.

  • Fred Alger Management's largest Q2 2024 buy was Applovin: 3,492,613 shares worth $291M.
  • Fred Alger Management added most to Constellation Energy in Q2 2024, an estimated $108M increase.
  • Fred Alger Management's biggest Q2 2024 reduction was Natera, cutting an estimated $130M.
  • Fred Alger Management fully exited Shockwave Medical, Inc. Common Stock in Q2 2024, selling an estimated $67.4M.
  • Fred Alger Management's ten largest holdings make up 46% of its $20.6B portfolio in Q2 2024.
  • Fred Alger Management opened 43 new positions and closed 61 in Q2 2024.
  • Fred Alger Management's portfolio value rose 2% quarter-over-quarter to $20.6B.

Based on Fred Alger Management's 13F filing for Q2 2024, filed 14 Aug 2024.